# Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

> **NCT04176224** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 9 (actual)

## Conditions studied

- Japanese Patients With ALS

## Interventions

- **DRUG:** MT-1186

## Key facts

- **NCT ID:** NCT04176224
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2019-09-04
- **Final completion:** 2019-09-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04176224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04176224, "Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04176224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*